These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14720455)

  • 61. S-Adenosylmethionine, cytokines, and alcoholic liver disease.
    McClain CJ; Hill DB; Song Z; Chawla R; Watson WH; Chen T; Barve S
    Alcohol; 2002 Jul; 27(3):185-92. PubMed ID: 12163148
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oxidative mechanisms in the pathogenesis of alcoholic liver disease.
    Albano E
    Mol Aspects Med; 2008; 29(1-2):9-16. PubMed ID: 18045675
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients.
    Chao YC; Young TH; Tang HS; Hsu CT
    Hepatology; 1997 Jan; 25(1):112-7. PubMed ID: 8985275
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.
    Singh S; Osna NA; Kharbanda KK
    World J Gastroenterol; 2017 Sep; 23(36):6549-6570. PubMed ID: 29085205
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.
    Hasegawa T; Yoneda M; Nakamura K; Makino I; Terano A
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1667-72. PubMed ID: 11564008
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatoprotective effects of Methyl ferulic acid on alcohol-induced liver oxidative injury in mice by inhibiting the NOX4/ROS-MAPK pathway.
    Li C; Li L; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW
    Biochem Biophys Res Commun; 2017 Nov; 493(1):277-285. PubMed ID: 28890346
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The role of oxidative stress in alcoholic liver injury].
    Radosavljević T; Mladenović D; Vucević D
    Med Pregl; 2009; 62(11-12):547-53. PubMed ID: 20491381
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view.
    Testino G; Leone S; Ansaldi F; Borro P
    Minerva Gastroenterol Dietol; 2013 Dec; 59(4):341-56. PubMed ID: 24212353
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment of acute alcoholic alcoholism].
    Michel H; Larrey D; Blanc P
    Ann Gastroenterol Hepatol (Paris); 1993; 29(1):29-39. PubMed ID: 7680191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alcohol and antioxidant systems.
    Nordmann R
    Alcohol Alcohol; 1994 Sep; 29(5):513-22. PubMed ID: 7811335
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alcoholic hepatitis: from pathogenesis to treatment.
    Sougioultzis S; Dalakas E; Hayes PC; Plevris JN
    Curr Med Res Opin; 2005 Sep; 21(9):1337-46. PubMed ID: 16197651
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Can alcohol damage of the liver be controlled by drugs?].
    Teschke R
    Z Gastroenterol; 1987 May; 25(5):274-8. PubMed ID: 3617842
    [No Abstract]   [Full Text] [Related]  

  • 73. Medical treatment for alcoholic liver disease.
    Ramond MJ; Rueff B; Benhamou JP
    Baillieres Clin Gastroenterol; 1993 Sep; 7(3):697-716. PubMed ID: 8219407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
    Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
    Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New paradigms in management of alcoholic hepatitis: a review.
    Sidhu SS; Goyal O; Kishore H; Sidhu S
    Hepatol Int; 2017 May; 11(3):255-267. PubMed ID: 28247264
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2001; (3):CD002148. PubMed ID: 11687017
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biochemical factors in alcoholic liver disease.
    Lieber CS
    Semin Liver Dis; 1993 May; 13(2):136-53. PubMed ID: 8337602
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Treatment of alcoholic liver diseases. Abstinence, nutritional support, drug therapy, liver transplantation].
    Pár A
    Orv Hetil; 2000 Apr; 141(16):827-33. PubMed ID: 10817009
    [TBL] [Abstract][Full Text] [Related]  

  • 79. S-adenosylmethionine attenuates oxidative liver injury in micropigs fed ethanol with a folate-deficient diet.
    Villanueva JA; Esfandiari F; White ME; Devaraj S; French SW; Halsted CH
    Alcohol Clin Exp Res; 2007 Nov; 31(11):1934-43. PubMed ID: 17850216
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevention and treatment of liver fibrosis based on pathogenesis.
    Lieber CS
    Alcohol Clin Exp Res; 1999 May; 23(5):944-9. PubMed ID: 10371420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.